Investing.com - Financial Markets Worldwide

Herborium Group Inc (HBRM)

OTC Markets
Currency in USD
0.00
0.00(0.00%)
Delayed Data·
HBRM Scorecard
Full Analysis
Stock has taken a big hit over the last week
HBRM is not included in our AI-picked strategies. See which stocks are.
Fair Value
Unlock Value
Day's Range
0.000.00
52 wk Range
0.000.00
Key Statistics
Edit
Prev. Close
-
Open
-
Day's Range
-
52 wk Range
0-0
Volume
-
Average Volume (3m)
2.24M
1-Year Change
-
Book Value / Share
-
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
HBRM Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Technical Analysis
Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Unlock All 11
Stock generally trades with high price volatility
Unlock InvestingPro

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Neutral
Moving Averages
Strong Sell

Herborium Group Inc Company Profile

Herborium Group, Inc., a botanical therapeutics company, develops, licenses, and markets proprietary, botanical based medicinal products to consumers and healthcare professionals. It offers dermatology products, which include AcnEase, herbal medicinal product for enhancing conditions associated with hormonal acne and multiple symptoms of Rosacea; and AcnEase Skin Management System for the treatment of acne marks/scars. The company also provides sexual health and performance products that are non-prescriptive alternatives to selected sexual disorders resulting from cardiovascular disease, use of anti-depressants, and surgical procedures, including hysterectomy. In addition, it offers energy restoration products, such as Lasting Energy, a herbal supplement to decrease the symptoms associated with hangovers and eliminating jet-lag; and for treating overall depletion of energy due to competitive sports, high levels of stress, and extensive sexual activities, as well as other long term or temporary physical demands. Further, the company provides Liver Activator Series for the treatment of liver damage; ProstAid, a natural product focuses on Benign Prostate Hyperplasia; and CardioVitae, a fermentation based product using a Lucidium derived cell line targeting cardio-pulmonary insufficiencies. Herborium Group, Inc. sells its products in the United States, the United Kingdom, and continental Europe through a network of distributors, specialty retailers, and e-commerce. The company was founded in 2000 and is headquartered in Fort Lee, New Jersey.

Industry
Biotechnology & Medical Research
Sector
Healthcare
Employees
5
Market
United States

Compare HBRM to Peers and Sector

Metrics to compare
HBRM
Peers
Sector
Relationship
P/E Ratio
0.0x−29.5x12.2x
PEG Ratio
0.00−0.280.03
Price/Book
0.0x0.6x1.5x
Price / LTM Sales
0.0x2.2x0.9x
Upside (Analyst Target)
0.0%71.8%17.3%
Fair Value Upside
Unlock43.4%11.0%Unlock

Earnings

Latest Release
Jan 29, 2025
EPS / Forecast
0.24 / --
Revenue / Forecast
67.00K / --
EPS Revisions
a
a
Unlock
Last 90 days

HBRM Income Statement

FAQ

What Stock Exchange Does Herborium Trade On?

Herborium is listed and trades on the OTC Markets stock exchange.

What Is the Stock Symbol for Herborium?

The stock symbol for Herborium is "HBRM."

What Is the Herborium Market Cap?

As of today, Herborium market cap is 10.92K.

What Is Herborium's Earnings Per Share (TTM)?

The Herborium EPS (TTM) is 0.11.

From a Technical Analysis Perspective, Is HBRM a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.

How Many Times Has Herborium Stock Split?

Herborium has split 2 times.

How Many Employees Does Herborium Have?

Herborium has 5 employees.

What is the current trading status of Herborium (HBRM)?

As of 30 Jul 2025, Herborium (HBRM) is trading at a price of 0.00, with a previous close of 0.00. The stock has fluctuated within a day range of 0.00 to 0.00, while its 52-week range spans from 0.00 to 0.00.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.